Personal information

Verified email domains

Activities

Employment (1)

Riga Stradiņš University: Riga, LV

2024-01-02 to present | Research assistant (1 Cell and Tissue Culture group, Institute of Microbiology and Virology, Riga Stradins University Science Hub)
Employment
Source: Self-asserted source
Olesja Rogoza

Education and qualifications (3)

University of Latvia: Riga, LV

2023 to present | Doctoral Degree of Science, Doctor of Science (Ph.D.) in Natural Sciences (Biology)
Education
Source: Self-asserted source
Olesja Rogoza

University of Latvia: Riga, LV

2021 to 2023 | Master of Science in Biology (Biology)
Education
Source: Self-asserted source
Olesja Rogoza

University of Latvia: Riga, LV

2018 to 2021 | Bachelor of Natural Sciences in Biology (Biology)
Education
Source: Self-asserted source
Olesja Rogoza

Professional activities (1)

European Association for Cancer Research: Riga, LV

2024-11 to present | Member, student
Membership
Source: Self-asserted source
Olesja Rogoza

Works (4)

Citizen Science in Biomedicine: Attitudes, Motivation, and Concerns of the General Public and Scientists in Latvia

Social Sciences
2023-11-08 | Journal article
Part of ISSN: 2076-0760
Contributors: Alise Svandere; Signe Mežinska; Jekaterina Kaleja; Normunds Kante; Raitis Peculis; Olesja Rogoza; Vita Rovite
Source: Self-asserted source
Olesja Rogoza

Transcriptome of GH-producing pituitary neuroendocrine tumours and models are significantly affected by somatostatin analogues

Cancer Cell International
2023-02-11 | Journal article
Part of ISSN: 1475-2867
Contributors: Rihards Saksis; Olesja Rogoza; Helvijs Niedra; Kaspars Megnis; Ilona Mandrika; Inga Balcere; Liva Steina; Janis Stukens; Austra Breiksa; Jurijs Nazarovs et al.
Source: Self-asserted source
Olesja Rogoza

Role of Somatostatin Signalling in Neuroendocrine Tumours

International Journal of Molecular Sciences
2022-01-27 | Journal article
Part of ISSN: 1422-0067
Contributors: Olesja Rogoza; Kaspars Megnis; Marija Kudrjavceva; Aija Gerina-Berzina; Vita Rovite
Source: Self-asserted source
Olesja Rogoza

Medication for Acromegaly Reduces Expression of MUC16, MACC1 and GRHL2 in Pituitary Neuroendocrine Tumour Tissue

Frontiers in Oncology
2021-02-15 | Journal article
Part of ISSN: 2234-943X
Contributors: Rihards Saksis; Ivars Silamikelis; Pola Laksa; Kaspars Megnis; Raitis Peculis; Ilona Mandrika; Olesja Rogoza; Ramona Petrovska; Inga Balcere; Ilze Konrade et al.
Source: Self-asserted source
Olesja Rogoza